Fibroblast growth factor receptor 2, gain-of-function mutations, and tumourigenesis: investigating a potential link

Ruth M S Hansen1, Anne Goriely, Steven A Wall

  • 1Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, Oxford OX3 9DS, UK.

Insights

Activating fibroblast growth factor receptor 2 (FGFR2) mutations are not common in tumors. This study found no evidence of dominant FGFR2 mutations in various tumor cell lines or testicular germ cell tumors.

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Background:

  • Activating germline mutations in fibroblast growth factor receptor (FGFR) genes cause skeletal disorders.
  • FGFR3 mutations are found in both inherited disorders and tumors.
  • The role of FGFR2 mutations in cancer is not well-defined, despite their known association with congenital syndromes.

Purpose of the Study:

  • To investigate the prevalence of fibroblast growth factor receptor 2 (FGFR2) mutations in various tumor types.
  • To determine if gain-of-function FGFR2 mutations contribute to tumorigenesis, particularly in testicular germ cell tumors.

Main Methods:

  • Analysis of 58 tumor cell lines and 29 testicular germ cell tumor samples.
  • Utilized denaturing high-performance liquid chromatography (DHPLC), DNA sequencing, and restriction digestion to detect FGFR2 mutations.

Main Results:

  • Sequence variations and allelic imbalance in FGFR2 were identified.
  • No previously documented dominant gain-of-function FGFR2 mutations were found in any of the examined tumor types.
  • This suggests FGFR2 mutations do not commonly drive tumor formation.

Conclusions:

  • Gain-of-function FGFR2 mutations are not frequently observed in tumorigenesis.
  • FGFR2 mutations do not appear to play a significant role in the development of testicular germ cell tumors.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...